Complement in the Development of Post-Traumatic Epilepsy: Prospects for Drug Repurposing

Area of Science:

• Neuroscience
• Immunology
• Neurology

Background:

• Neuroinflammation plays a critical role in epileptogenesis, the development of epilepsy.
• Traumatic brain injury (TBI) triggers significant neuroinflammation, often leading to post-traumatic epilepsy.
• The complement system, a key part of innate immunity, contributes to brain damage and epileptogenesis after CNS injury.

Purpose of the Study:

• To review complement system activation in experimental models of TBI and epilepsy.
• To highlight the potential of repurposing existing complement-targeting drugs for treating post-traumatic epilepsy.

Main Methods:

• Literature review of studies on complement activation in TBI and epilepsy models.
• Analysis of existing therapeutic agents targeting the complement system.

Main Results:

• Evidence indicates complement system activation is a significant factor in secondary injury and epileptogenesis following CNS insults.
• Several complement-targeting drugs are available or in development for other neurological conditions.

Conclusions:

• The complement system is a promising therapeutic target for preventing and treating epilepsy after TBI.
• Repurposing complement inhibitors may offer a viable strategy for developing novel treatments for post-traumatic epilepsy.